Lodoz 5 mg/6,25 mg filmom obložene tablete
| Name | Lodoz 5 mg/6,25 mg filmom obložene tablete |
|---|---|
| Marketing Authorisation Number | HR-H-374007129 |
| Active Substance | bisoprololfumarat hidroklorotiazid |
| Composition | svaka filmom obložena tableta sadrži 5 mg bisoprololfumarata i 6,25 mg hidroklorotiazida |
| Pharmaceutical Form | filmom obložena tableta |
| Packaging [MA Number for Packaging] | 30 tableta u blisteru, u kutiji [HR-H-374007129-01] 90 tableta u blisteru, u kutiji [HR-H-374007129-02] |
| Manufacturer | Merck Sante s.a.s., Semoy, Francuska
Merck Healthcare KGaA, Darmstadt, Njemačka P&G Health Austria GmbH & Co. OG, Spittal an der Drau, Austrija |
| Marketing Authorisation Holder | Merck d.o.o., Oreškovićeva ulica 6H/1, Zagreb, Hrvatska |
| Marketing Authorisation Date | 30.09.2015 |
| MA Period of Validity | unlimited |
| Classification Number | UP/I-530-09/14-02/202 |
| Registration Number | 381-12-01/30-15-06 |
| Prescription | na recept |
| Type of prescription | ponovljivi recept |
| Distribution | u ljekarni |
| Advertising to general public | zabranjeno |
| ATC Code | C07BB07 |
| Medicinal product marketed in the Croatia | Da |
| SmPC | download |
| PL | download |
Direct Healthcare Professional Communication
| Name | Date | Download |
|---|---|---|
| Pismo zdravstvenim radnicima o riziku od nemelanomskog raka kože povezanog s primjenom hidroklorotiazida | 17.10.2018 | Alkaloid, Belupo, Berlin-Chemie Menarini, Boehringer Ingelheim International, Farmal, Genericon, Pharma, Jadran Galenski laboratorij, Krka - farma, Merck, Merck Sharp & Dohme, Novartis, PharmaSwiss, Pliva, Sandoz, sanofi-aventis i Stada |
